ASIA yields 1.05% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, ASIA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASIA + JNJ for your $10,000?
ASIA aims to invest in common and preferred stocks of Asian companies capable of sustainable growth. It taps into the Asia Pacific ex-Japan markets, covering developed, emerging, and frontier markets. The portfolio typically consists of mid- or large-cap companies, though it may consider companies of varying sizes based on book value, revenues, profits, cash flow, dividends, and employee count. The fund manager places a strong emphasis on fundamentals, selecting companies with strong balance sheets, cash flow stability, adaptability, integrity, product lines, marketing strategies, corporate governance, financial health, and effective management. ESG characteristics are also taken into consideration in the investment process. However, not all investments may exhibit strong ESG characteristics, and there could be instances when a company's ESG profile cannot be evaluated. The fund may also invest in depositary receipts, such as American, European, and Global Depositary Receipts.
Full ASIA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.